Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Stem Cells as an Enabling Technology in Drug Discovery

Stem cells (SCs) are emerging as a viable enabling technology for high throughput screening and lead discovery, and the replacement of mouse SCs with a reliable commercial source of large quantities of reproducible human SC populations will offer a major opportunity to improve the clinical predictability of preclinical drug discovery and development.

By Maria Webb at Ligand Pharmaceuticals (December 2009)

Keywords: stem cells, screening, lead discovery, webb, ligand pharmaceuticals,

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |